Approvals/TGA/RIVASTIGMINE GenPar PATCH 15 rivastigmine 13.3 mg/24 hours transdermal drug delivery system sachet

Approved

STANDARD

RIVASTIGMINE GenPar PATCH 15 rivastigmine 13.3 mg/24 hours transdermal drug delivery system sachet

Arrotex Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 1f602148ec8ff017
Product Name: RIVASTIGMINE GenPar PATCH 15 rivastigmine 13.3 mg/24 hours transdermal drug delivery system sachet
Artg Id: 273558
Artg Name: RIVASTIGMINE GenPar PATCH 15 rivastigmine 13.3 mg/24 hours transdermal drug delivery system sachet
Sponsor: Arrotex Pharmaceuticals Pty Ltd
Company Detail Path: /organization/arrotex-pharmaceuticals-pty-ltd
Artg Date: 2017-01-25
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

1f602148ec8ff017

Type

Standard